Health Condition 1: M750- Adhesive capsulitis of shoulder
Conditions
Interventions
Intervention1: HABB-E-ASGANDH And
ROGHAN-E-SHIBT: 1. Habb-e-Asgand
Dose:
2 tablets (300 mg each) twice daily per dose (total 600 mg dose per day)
Frequency:
Twice daily
Route of Administration:
Oral i
Sponsors
National Institute of Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: Patients with difficulty in shoulder movement (unilateral/bilateral). Symptoms present for more than 3 months. Clinically diagnosed cases of Adhesive capsulitis. Known case of Diabetes Mellitus and or Hypothyroidism with Adhesive capsulitis. Patient with decreased AROM more than50degree in two or more planes.
Exclusion criteria
Exclusion criteria: age less than 40 and more than 60 will be excluded Pregnancy and lactation. History of Shoulder injury and surgery, use of local corticosteroid injection within the last 3 months or current corticosteroid therapy. Shoulder symptoms due to causes other than AC. History of any systemic, metabolic, and infectious diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relief in Shoulder Pain and Improvement in AROM (SPADI (Shoulder Pain and Disability Index)Timepoint: 0th, 7th, 14th, and 21st day, with a post-treatment follow-up at 1 week | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in AROM (Goniometer). Improvement in Quality of Life (DASH). Subjective Parameters: Shoulder pain (VAS) and Difficulty in movement of the upper limb (VAS) Timepoint: 0th, 7th, 14th, and 21st day, with a post-treatment follow-up at 1 week | — |
Countries
India
Contacts
Public ContactDr Abdul Mobeen
National Institute of Unani Medicine,
Outcome results
None listed